Long-term survival outcomes after lobe-specific nodal dissection in patients with early non-small-cell lung cancer.
Atsushi KamigaichiKeiju AokageTakashi IkenoMasashi WakabayashiTomohiro MiyoshiKenta TaneJoji SamejimaMasahiro TsuboiPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2023)
LSD provides acceptable long-term survival for patients with early-stage NSCLC. However, LSD may not be suitable for patients with c-stage II NSCLC due to the higher mortality risk from primary lung cancer.